UAB researchers report that carriers of specific genetic variants face significantly elevated risks of heart failure, cardiomyopathy and arrhythmia, underscoring the potential benefits of targeted genetic screening.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

It is never too late for individuals to take steps to help manage their health as they age.

The finding of TREM2 as a critical regulator of macrophage-mediated fibrosis makes it a promising therapeutic target for intervention for lung fibrotic disease.

The American Heart Association’s PREVENT CVD risk equation is designed to help predict a person’s risk of a cardiovascular event during their lifetime.

The understanding of how macrophages regulate their response to toxic particles via two independent pathways could uncover therapeutic opportunities to quell inflammation.

An NLP-informed AGI clinic is a viable approach to efficiently improve the systemwide quality of care for patients with AGIs.

UAB is a stronghold at finding patients for studies, but healthy controls were harder.

UAB’s new Lunaphore COMET multiplex immunofluorescent platform can hyperplex up to 40 antibodies on a single pathology tissue sample.

Helping children develop healthy habits at a young age can help lower their risk for heart disease, stroke and other major health problems later in life.

When UAB employee Jamie Smith collapsed one morning while she was at work, UAB employees from multiple specialties stepped in to help save her life.

Experts at the UAB Cardiovascular Institute and UAB St. Vincent’s say it is never too early or too late for women to begin protecting themselves from heart disease.

With a $2.47 million gift from Novo Nordisk Inc., Live HealthSmart Alabama is applying its holistic health model in Selma, Camden, Demopolis and other underserved communities.

UAB researchers reveal how managing cardiovascular risk factors can mitigate heart failure risk in Black individuals carrying the transthyretin V142I genetic variant.

UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

Injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function, showing possible clinical relevance.

This study highlights how high-volume centers, where operators perform these procedures more frequently, achieve better outcomes, including lower 30-day mortality and reduced complication rates. 

Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are needed.

UAB is combating youth tobacco use with its ninth annual award from the Alabama Department of Public Health.

The goal of this project is to reduce health disparities in colonoscopy screening and colorectal cancer outcomes for vulnerable populations in Jefferson County.